TNF inhibitors (TNFis), including certolizumab pegol (CZP), adalimumab (ADA), etanercept (ETA), golimumab (GOL) and infliximab (IFX) are an effective treatment option for many patients with RA [9–18]. The gene discussed is TNF; the disease is rheumatoid arthritis.